TOTAL ALLERGY CARE for HEALTH PROFESSIONALS

Children’s ZYRTEC® Clinical Data

Children’s ZYRTEC® 5 mg provides a powerful symptom response1

In patients ages 2 to 6 years with seasonal allergic rhinitis (SAR)

Percentage of children demonstrating ≥50% improvement from baseline SAR symptoms over 2 weeks

Randomized, placebo-controlled study of children aged 2 to 6 years with SAR during a 2-week period. Primary endpoint was the change in Total Symptom Score Complex from baseline.

*Significant vs placebo.

ZYRTEC® 5 mg vs placebo ratio at ≥50% reduction is 1.84-fold.

Reference: 1. Data on file, Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division.

Children’s ZYRTEC® 10 mg delivers a powerful symptom response1

In patients ages 6 to 12 years with seasonal allergic rhinitis (SAR)

Percentage of children demonstrating ≥50% improvement from baseline SAR symptoms over 2 weeks

Randomized, placebo-controlled studies of children aged 6 to 12 years with SAR during a 2-week period. Primary endpoint was the change in Total Symptom Score Complex from baseline.

*Significant vs placebo.

ZYRTEC® 10 mg vs placebo ratio at ≥50% reduction is 1.88-fold in Study 1 and 1.42-fold in Study 2.

Reference: 1. Data on file, Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division.

Consistent relief of seasonal allergic rhinitis symptoms

Reduction from baseline in Total Symptom Severity Complex (TSSC)*†1

Improvement maintained throughout 2 weeks of regular use
  • Percent reductions from baseline TSSC score were 37% and 40%, respectively, after 2 weeks of treatment in the 10-mg group
  • Percent reductions from baseline TSSC score were 63% and 40%, respectively, after 2 weeks of treatment in the 5-mg group

All studies are multicenter, randomized, placebo-controlled, double-blind; children ages 2 to 11 years with previous diagnosis of SAR, and adequate minimum duration (2 weeks).

*TSSC = Total Symptom Severity Complex.

Adjusted mean change relative to baseline.

Reference: 1. Urdaneta ER, Przygoda PA, Lin CL, et al. Regular use of cetirizine demonstrates consistent relief from symptoms of seasonal allergic rhinitis in children. J Allergy Clin Immunol. 2011;127(suppl 2):AB 202.

Caregiver Brochure

Help educate children and caregivers about allergies with an educational brochure and storybook.

Help children and caregivers understand allergies Help children and caregivers understand allergies Help children and caregivers understand allergies

Learn more about Children's ZYRTEC®

TBD TBD TBD